Navigation Links
Outsourcing clinical trials to India

Clinical research in India costs has become very easy and cheap compared to other countries, which has lead to an increased outsourcing of clinical research to India.

Outsourcing in the field of IT can be taken as a boom to the economics and development of India, but Outsourcing in // clinical trials is a great havoc to India, as humans are becoming a source of experimental animals and being exploited.

Due to intensive and strict Animal guidelines using animals in India too has become a very problem, so the drug companies have shifted their trials to humans rather to animals.

India has a rich man power of very skilled and intelligent research and development scientists and also has a great population of people with many diseases and the non exposure of these people to drugs make them more interesting for the drug companies to test their new drugs.

India has 30 million people in India have heart diseases, 25 million have type-II diabetes and 10 million suffer psychiatric disorders, and notes recruits in India are more likely to comply fully with the trial processes. An other important reason for considering India for clinical trial is availability of man power at a comparatively cheaper salaries, it is estimated that 20-30 percent of cost is saved by hiring clinical researchers, nurses and IT staff from India in addition to costs associated with patients.

The report also says India's newly adopted guidelines on "good clinical practices" and "patient consent norms" are in line with global rules, while saying commentators have also questioned consent from illiterate patients.

Source: Indo-Asian News Service
'"/>




Page: 1

Related medicine news :

1. Outsourcing Medical Records Risky: Unison
2. Lab Tests And Diagnostics - Next Wave Of Outsourcing
3. GlaxoSmithKline Signs Outsourcing Deal With TCS
4. Outsourcing Farming, a Chinese Initiative
5. Outsourcing of UK Hospital Records to India Opposed
6. How do patients benefit of clinical trials
7. Magnetic resonance angiography in clinical medicine
8. AEternas acquisition of Zentaris being followed up with its new product pipeline and clinical development strategy
9. Erectile dysfunction: an early warning sign of clinically silent coronary artery disease?
10. India to maintain Public domain Registry database of clinical trials conducted in India.
11. Diagnosis of Alzheimers years before clinical signs emerge
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... ... March 29, 2017 , ... ... of Pittsburgh now have easier access to the robotic-assisted total-hip and partial-knee ... Network (AHN). Orthopaedic surgeons at Forbes Hospital and Jefferson Hospital recently started ...
(Date:3/29/2017)... ... 2017 , ... The Wharton School of the University of Pennsylvania is pleased ... a $10 million gift to establish the Ken Moelis and Julie Taffet Moelis ... a Wharton MBA for highly-qualified Penn undergraduates whose academic and career interests expand traditional ...
(Date:3/29/2017)... ... 29, 2017 , ... VisualSP has helped over 1.5 million SharePoint users learn ... on-premises installation of its Help System for SharePoint was at the farm level. Enterprises ... entire tenant. , The company recently released a modified version of the Help ...
(Date:3/28/2017)... ... March 28, 2017 , ... Tuesday, March 28, 2017, is the annual ... the Diabetes Risk Test to find out if they are at risk for developing ... light up the evening sky by programming the LAX pylons the color red. Downtown’s ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... first technology to directly address the resolution to globally reduce the harmful use ... patented compound of FDA and TTB approved ingredients that when infused into alcohol, ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... TAIPEI, Taiwan , March 28, 2017 /PRNewswire/ ... medical device company, is pleased to announce ... Series A investment of Panther Orthopedics, Inc., a ... pioneering innovative dynamic fixation solutions for orthopedic extremity ... market continues to expand rapidly, primarily due to ...
(Date:3/28/2017)...  "US Cancer Generics Market Outlook 2022" report ... trend analysis related to the emergence and integration ... in US. The report analyzes various clinical and ... generics drugs in recent years. The introduction of ... dollars for various stake holders involved US cancer ...
(Date:3/28/2017)... -- Orexigen Therapeutics, Inc. (Nasdaq: OREX ) today ... and year ended December 31, 2016. ... Orexigen, beginning with the re-acquisition of the rights to ... team at Orexigen demonstrated remarkable focus, executing on a ... our Company while rewarding us full control of our ...
Breaking Medicine Technology: